97 related articles for article (PubMed ID: 8164782)
1. [Cytotoxic cytokines in multiple sclerosis].
Głabiński A
Neurol Neurochir Pol; 1993; 27(6):869-75. PubMed ID: 8164782
[TBL] [Abstract][Full Text] [Related]
2. The role of TNFalpha and lymphotoxin in demyelinating disease.
Lock C; Oksenberg J; Steinman L
Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I121-8. PubMed ID: 10577988
[No Abstract] [Full Text] [Related]
3. Multiple sclerosis: expression of molecules of the tumor necrosis factor ligand and receptor families in relationship to the demyelinated plaque.
Raine CS; Bonetti B; Cannella B
Rev Neurol (Paris); 1998 Sep; 154(8-9):577-85. PubMed ID: 9809372
[TBL] [Abstract][Full Text] [Related]
4. Tumour necrosis factor and lymphotoxin: molecular aspects and role in tissue-specific autoimmunity.
Körner H; Sedgwick JD
Immunol Cell Biol; 1996 Oct; 74(5):465-72. PubMed ID: 8912010
[TBL] [Abstract][Full Text] [Related]
5. Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2+ T cells.
Zipp F; Weber F; Huber S; Sotgiu S; Czlonkowska A; Holler E; Albert E; Weiss EH; Wekerle H; Hohlfeld R
Ann Neurol; 1995 Nov; 38(5):723-30. PubMed ID: 7486863
[TBL] [Abstract][Full Text] [Related]
6. Immunologic aspects of multiple sclerosis.
Taylor RS
Phys Med Rehabil Clin N Am; 1998 Aug; 9(3):525-36, v. PubMed ID: 9894106
[TBL] [Abstract][Full Text] [Related]
7. Lymphotoxin production in multiple sclerosis patients.
Głabiński A; Pokoca L; Tchórzewski H; Selmaj K
Arch Immunol Ther Exp (Warsz); 1991; 39(3):285-90. PubMed ID: 1810221
[TBL] [Abstract][Full Text] [Related]
8. Multiple sclerosis: the proinflammatory cytokines lymphotoxin-alpha and tumour necrosis factor-alpha are upregulated in cerebrospinal fluid mononuclear cells.
Matusevicius D; Navikas V; Söderström M; Xiao BG; Haglund M; Fredrikson S; Link H
J Neuroimmunol; 1996 May; 66(1-2):115-23. PubMed ID: 8964905
[TBL] [Abstract][Full Text] [Related]
9. Astroglial-derived lymphotoxin-alpha exacerbates inflammation and demyelination, but not remyelination.
Plant SR; Arnett HA; Ting JP
Glia; 2005 Jan; 49(1):1-14. PubMed ID: 15382206
[TBL] [Abstract][Full Text] [Related]
10. Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
Bar-Or A; Fawaz L; Fan B; Darlington PJ; Rieger A; Ghorayeb C; Calabresi PA; Waubant E; Hauser SL; Zhang J; Smith CH
Ann Neurol; 2010 Apr; 67(4):452-61. PubMed ID: 20437580
[TBL] [Abstract][Full Text] [Related]
11. Immune-mediated demyelination.
Hartung HP
Ann Neurol; 1993 Jun; 33(6):563-7. PubMed ID: 8498835
[TBL] [Abstract][Full Text] [Related]
12. A novel microRNA-132-sirtuin-1 axis underlies aberrant B-cell cytokine regulation in patients with relapsing-remitting multiple sclerosis [corrected].
Miyazaki Y; Li R; Rezk A; Misirliyan H; Moore C; Farooqi N; Solis M; Goiry LG; de Faria Junior O; Dang VD; Colman D; Dhaunchak AS; Antel J; Gommerman J; Prat A; Fillatreau S; Bar-Or A; ;
PLoS One; 2014; 9(8):e105421. PubMed ID: 25136908
[TBL] [Abstract][Full Text] [Related]
13. [Cytokines in MS lesion].
Kato H; Suzumura A
Nihon Rinsho; 2003 Aug; 61(8):1428-34. PubMed ID: 12962034
[TBL] [Abstract][Full Text] [Related]
14. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions.
Selmaj K; Raine CS; Cannella B; Brosnan CF
J Clin Invest; 1991 Mar; 87(3):949-54. PubMed ID: 1999503
[TBL] [Abstract][Full Text] [Related]
15. Distinction of partially purified human natural killer cytotoxic factor from recombinant human tumor necrosis factor and recombinant human lymphotoxin.
Bialas T; Kolitz J; Levi E; Polivka A; Oez S; Miller G; Welte K
Cancer Res; 1988 Feb; 48(4):891-8. PubMed ID: 3257413
[TBL] [Abstract][Full Text] [Related]
16. The presence of antibodies to lymphotoxin and tumor necrosis factor in normal serum.
Jeffes EW; Ininns EK; Schmitz KL; Yamamoto RS; Dett CA; Granger GA
Arthritis Rheum; 1989 Sep; 32(9):1148-52. PubMed ID: 2789046
[TBL] [Abstract][Full Text] [Related]
17. Genetic models for CNS inflammation.
Owens T; Wekerle H; Antel J
Nat Med; 2001 Feb; 7(2):161-6. PubMed ID: 11175845
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic activities of recombinant soluble murine lymphotoxin-alpha and lymphotoxin-alpha beta complexes.
Mackay F; Bourdon PR; Griffiths DA; Lawton P; Zafari M; Sizing ID; Miatkowski K; Ngam-ek A; Benjamin CD; Hession C; Ambrose CM; Meier W; Browning JL
J Immunol; 1997 Oct; 159(7):3299-310. PubMed ID: 9317128
[TBL] [Abstract][Full Text] [Related]
19. Network communications: lymphotoxins, LIGHT, and TNF.
Ware CF
Annu Rev Immunol; 2005; 23():787-819. PubMed ID: 15771586
[TBL] [Abstract][Full Text] [Related]
20. Signalling pathways of the TNF superfamily: a double-edged sword.
Aggarwal BB
Nat Rev Immunol; 2003 Sep; 3(9):745-56. PubMed ID: 12949498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
